# FDA Inspection 1199001 - Octapharma Plasma Inc - February 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/428e4b70-3294-4dec-85bb-fb33503dfd9a
Source feed: FDA_Inspections

> FDA Inspection 1199001 for Octapharma Plasma Inc on February 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1199001
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-02-15
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1199001 - 2023-02-15](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e9063fa0-b0a5-403f-9c99-5bf56d6c0375)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/982e801b-fa3a-46f9-b89e-db0668688bd6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d